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NEWS & VIEWS
Does Influenza A Infection Increase Oxidative Damage?
Mary P.E. Ng,1 Jetty C.Y. Lee,2 Wai Mun Loke,3 Leonard L.L. Yeo,4 Amy M.L. Quek,4
Erle C.H. Lim,1,4 Barry Halliwell,5 and Raymond Chee-Seong Seet1,4
Abstract
Considerable data implicate oxidative damage in influenza pathogenesis. We examined temporal changes in
oxidative damage using accurate biomarkers in an adult cohort with acute influenza infection and their
relationships with clinical parameters. Clinical information and blood samples were collected during their
acute illness and 3 months later. A fatigue questionnaire was administered 3 months following influenza
infection. Thirty-five patients (mean age, 34 years) with polymerase chain reaction-confirmed influenza A
infection were included; all patients returned for follow-up assessments. Adjusted levels of plasma
F2-isoprostanes, total hydroxyeicosatetraenoic products (HETEs), 7b-hydroxycholesterol and 7-ketocholesterol,
serum gamma-glutamyltransferase, and high-sensitivity C-reactive protein (hsCRP) were increased during
the acute illness compared with age-matched controls. Despite clinical recovery, levels of these biomarkers
remained higher at month 3 compared with controls. A proportion of patients had persistent symptoms such as
fatigue (23%), myalgia (14%), and arthralgia (11%) at month 3. Patients with significant fatigue had higher
baseline levels of plasma F2-isoprostanes, F4-neuroprostanes, and total HETEs compared to those without
fatigue. By contrast, patients with persistent arthralgia and myalgia had higher baseline levels of serum
hsCRP compared to those without these symptoms. Our observations lead to the hypothesis that oxidative
damage participates in the pathogenesis of influenza infection and postinfectious fatigue. Antioxid. Redox
Signal. 21, 1025–1031.
Introduction
Some evidence suggests a role for reactive oxygen spe-cies (ROS) in influenza pathogenesis. In humans, the
involvement of oxidative damage is suggested by lower
plasma levels of antioxidants in children with influenza in-
fection (3). Autopsy analysis of lung tissues from patients
with influenza A pneumonia showed intense staining for
oxidized dihydroethidium, indicating increased generation of
oxygen radicals during severe infection (5). In healthy indi-
viduals, a challenge with live attenuated influenza vaccine
elicited a prompt and sustained increase in biomarkers of
oxidative stress in the breath (6). Available studies, however,
have not evaluated the temporal changes of oxidative damage
in influenza patients using accurate biomarkers. It is also
Innovation
Oxidative damage is increased during acute infec-
tion and is persistently elevated despite clinical recovery
from influenza infection. Despite a relatively mild ill-
ness, this study revealed a proportion of patients with
persistent symptoms of fatigue, myalgia, and arthral-
gia late into the disease, beyond the initial clinical re-
covery. Our observations lead to the hypothesis that
oxidative damage is involved in the pathogenesis of in-
fluenza infection and postinfectious fatigue. These find-
ings have important implications in the design of clinical
trials investigating the roles of antioxidants in influenza
infection.
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unclear whether oxidative damage is involved in the devel-
opment of postinfluenza fatigue.
We prospectively investigated the temporal changes in
oxidative damage among patients with influenza infection
and compared them with clinical outcomes. Biomarkers that
target different aspects of oxidative damage [including
F2-isoprostanes, F4-neuroprostanes, cholesterol oxidation
products (COPs), allantoin, and gamma-glutamyltransferase
(GGT) (4)], were measured. We also examined total hydro-
xyeicosatetraenoic products (HETEs), which are potent in-
flammatory mediators, and the high-sensitivity C-reactive
protein (hsCRP).
Results
Participants
All subjects were diagnosed by the attending physician to
have acute influenza A infection, confirmed from nasopha-
ryngeal swabs by real-time polymerase chain reaction.
Thirty-five patients (mean age 34, range 21–63 years; 66%
men) were recruited and reassessed 3 months later. Seventy
age-matched subjects were recruited as controls. The clinical
characteristics of these patients are summarized in Table 1.
Noteworthy is the increase in blood pressure parameters
during acute illness compared with levels 3 months later.
Cases and controls were comparable in terms of gender, body
mass index, and medical comorbidities (data not shown).
During acute illness, the mean sum of symptom score was
8.3; this mean score decreased to 0.5 three months later
( p < 0.0001). Symptoms such as fever (97%), headache
(86%), poor appetite (63%), myalgia (49%), and arthralgia
(46%), were common (Table 2). Three months after their
acute illness, nine (26%) subjects had persistent symptoms
despite resolution of their initial symptoms. Significant fa-
tigue was observed in eight (23%) subjects, whereas a pro-
portion had persistent musculoskeletal symptoms such as
myalgia (14%) and arthralgia (11%) (Table 2). None of the
controls reported any symptoms.
Effects of influenza infection on biomarkers
Lipid oxidation products. Compared with controls, plas-
ma arachidonate levels of patients with influenza infection
were lower during acute illness and 3 months later (Fig. 1A).
Although serum cholesterol levels were lower during acute
illness compared with controls, there were no differences in
cholesterol levels compared with month 3 (Fig. 1B). By
contrast, plasma docosahexaenoate levels were higher during
acute illness and at month 3 compared with controls; higher
levels were observed at month 3 compared with those dur-
ing acute illness (Fig. 1C). Given these differences, lipid
oxidation products are presented per unit of their respective
precursors.
Plasma F2-isoprostanes (before and after adjusting for
arachidonate) were higher during acute illness compared with
levels at month 3 and those of controls (Fig. 2A, B). A
nonsignificant increase in urinary F2-isoprostanes (per unit
creatinine) was observed during acute illness compared with
controls; urinary F2-isoprostanes (per unit creatinine) tended
to be higher at month 3 compared with during the acute ill-
ness. Despite clinical recovery 3 months later, plasma and
urinary levels of F2-isoprostanes (per unit creatinine) were
persistently higher than control levels (Fig. 2A–C). Plasma
7b-hydroxycholesterol and 7-ketocholesterol (per unit cho-
lesterol) were significantly increased during acute illness
Table 1. Clinical and Laboratory Parameters
Clinical information
Acute illness
(n = 35)
Month 3
(n= 35)
Age (years) 34.1 (12.3)
Sex (%)
Male 23 (66)
Female 12 (34)
Weight (kg) 69.8 (14.7) 70.7 (14.7)
Body mass index (kg/m2) 24.1 (5.8) 25.3 (4.7)
Systolic blood pressure
(mmHg)a
135 (18) 124 (14)
Diastolic blood pressure
(mmHg)a
83 (11) 77 (11)
Body temperature (C)a 37.5 (0.9) 36.4 (0.4)
Risk factors (%)
Asthma 10 (29)
Hypertension 6 (17)
Cigarette smoking 6 (17)
Hyperlipidemia 5 (14)
Ischemic heart disease 3 (9)
Diabetes mellitus 2 (6)
Laboratory results
Lipid profile
Triglycerides (mM) 1.5 (1.1) 1.6 (0.8)
High-density lipoprotein
(mM)
1.2 (0.4) 1.2 (0.4)
Low-density lipoprotein
(mM)
3.2 (1.0) 3.2 (1.1)
Creatinine (lM) 90.3 (77.2) 85.2 (76.7)
Glucose (mM) 5.2 (1.9) 5.5 (2.4)
Urea (mM) 4.4 (2.6) 4.9 (2.8)
Alkaline phosphatase (U/L) 79 (69–92) 76 (58–89)
Alkaline transaminases
(U/L)
30 (17–43) 29 (18–48)
Aspartate transaminases
(U/L)
29 (23–40) 27 (21–37)
Values are expressed as mean (standard deviation) or median
(interquartile range).
ap< 0.05.
Table 2. Symptom Frequency
Acute illness (%) Month 3 (%)
Symptoms Score 0 Score 1–3 Score 0 Score 1–3
Fever 1 (3) 34 (97) 35 (100) 0 (0)
Nausea and
vomiting
21 (60) 14 (40) 34 (97) 1 (3)
Abdominal
pain
24 (69) 11 (31) 35 (100) 0 (0)
Diarrhea 26 (74) 9 (26) 35 (100) 0 (0)
Poor appetite 13 (37) 22 (63) 33 (94) 2 (6)
Headaches 5 (14) 30 (86) 32 (91) 3 (9)
Arthralgia 19 (54) 16 (46) 31 (89) 4 (11)
Myalgia 18 (51) 17 (49) 30 (86) 5 (14)
Total
symptom
score
0 (0) 35 (100) 26 (74) 9 (26)
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compared with levels of controls and those 3 months later
(Fig. 3A, B). Similarly, plasma 7b-hydroxycholesterol and
7-ketocholesterol (per unit cholesterol) did not normalize and
remained higher than controls 3 months later. Conversely,
plasma F4-neuroprostanes (before and after adjusting for
docosahexaenoate) were lower during the acute illness and at
month 3 as compared with controls; levels measured during
acute illness were higher compared with those at month 3
(Fig. 3C, D).
Urate, allantoin, and GGT. During acute illness, plasma
urate was significantly lower than controls; these levels in-
creased at month 3, but remained lower compared with
controls (Fig. 4A). By contrast, plasma allantoin was higher
during acute illness compared with controls and increased
further at month 3 (Fig. 4B). Serum GGT was significantly
increased during acute illness compared with controls
(Fig. 4C). Although serum GGT trended lower at month 3,
GGT levels remained higher than controls.
Total HETEs, hsCRP, nitrite, and nitrate. Plasma total
HETEs (per unit arachidonate) and serum hsCRP levels
were higher during acute illness compared with controls (Fig.
5A, B). Although levels were lower at month 3 compared
with during acute illness, these biomarkers did not normalize
to levels of controls. By comparison, plasma nitrite and ni-
trate were lower during acute illness compared with controls,
these levels increased significantly at month 3. Notably,
levels of plasma nitrite were higher at month 3 compared with
controls (Fig. 5C, D).
Correlations between biomarkers and clinical parameters
Significant correlation was observed between age and
plasma docosahexaenoate (acute illness: r = 0.43, p = 0.01;
month 3: r = 0.41, p= 0.01), but not with the other measured
biomarkers. No differences in biomarkers were observed
between genders. Plasma nitrite was observed to correlate
positively with systolic blood pressure during acute illness
(r = 0.38, p = 0.029); this relationship, however, was not seen
3 months later. No significant correlation was found between
systolic and diastolic blood pressure and plasma nitrate,
arachidonate, F2-isoprostanes, total HETEs, F4-neuropros-
tanes, COPs, and allantoin during acute illness and 3 months
later. Similarly, there was no correlation between body
weight, height, body mass index, and smoking status and the
measured biomarkers.
Comparisons between biomarkers and clinical features
During acute illness and at month 3, there were no sig-
nificant correlations between biomarker levels and symptom
scores. Post hoc analyses were performed to examine the
relationship between levels of biomarkers among subjects
with and without significant fatigue, myalgia, and arthralgia.
Patients with significant fatigue had higher acute levels
of plasma F2-isoprostanes, F4-neuroprostanes, total HETEs,
FIG. 1. Comparisons in the levels of (A) plasma arachidonate, (B) serum cholesterol, and (C) plasma docosahex-
aenoate in age-matched controls (n570) and influenza patients (n535). Each graphical column expresses
mean – standard deviation. *p< 0.05 using the unpaired Student’s t-test versus controls, while #p < 0.05 using the paired t-
test between acute illness and at month 3.
FIG. 2. Comparisons in the (A) unadjusted levels of plasma F2-isoprostanes, (B) adjusted levels of plasma F2-
isoprostanes, and (C) urinary F2-isoprostanes between age-matched controls and patients during acute illness and at
month 3. Each graphical column expresses mean – standard deviation. *p< 0.05 using the unpaired Student’s t-test versus
controls, while #p< 0.05 using the paired t-test between acute illness and at month 3.
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and serum hsCRP compared to those without fatigue
(Fig. 6A–D). No differences were observed between fatigue
and arachidonate, docosahexaenoate, COPs, urate, nitrite,
nitrate, and GGT. There were no differences in these bio-
markers measured at month 3 between subjects with and
without fatigue (data not shown). At month 3, subjects with
persistent arthralgia and myalgia had higher acute levels
of serum hsCRP compared with those without arthralgia
and myalgia (Fig. 7A, B). No significant relationship was
observed between biomarkers of oxidative damage and these
musculoskeletal symptoms.
Discussion and Future Directions
Biomarkers of oxidative damage were rigorously assessed
in patients with influenza infection. This study is the first to
examine postinfectious fatigue in influenza patients and im-
plicates oxidative damage in its pathogenesis. Despite
FIG. 3. Comparisons in the adjusted levels of (A) plasma 7b-hydroxycholesterol, (B) plasma 7-ketocholesterol, (C)
unadjusted plasma F4-neuroprostanes, and (D) adjusted plasma F4-neuroprostanes between age-matched controls and
patients during acute illness and at month 3. Each graphical column expresses mean– standard deviation. *p< 0.05 using
the unpaired Student’s t-test versus controls, while #p< 0.05 using the paired t-test between acute illness and at month 3.
FIG. 4. Comparisons in the adjusted levels of (A) plasma urate, (B) plasma allantoin, and (C) serum gamma-
glutamyltransferase between age-matched controls and patients during acute illness and at month 3. Each graphical
column expresses mean – standard deviation. *p < 0.05 using the unpaired Student’s t-test versus controls, while #p < 0.05
using the paired t-test between acute illness and at month 3.
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apparent clinical recovery, a proportion of patients had per-
sistent elevation in these biomarkers compared with controls.
The strengths of this study include the prospective study
design, use of paired clinical and biomarker determination,
and measurement of accurate biomarkers of oxidative dam-
age.
Plasma F2-isoprostanes were observed to be higher during
acute illness compared with recovery levels and those of
controls. The increase in oxidative damage is also suggested
by an increase in several biomarkers of lipid peroxidat-
ion such as 7b-hydroxycholesterol and 7-ketocholesterol.
These biomarkers remain elevated despite clinical recovery 3
months later. Contrary to our previous findings in dengue
patients (7), we did not observe an association between
plasma total HETEs and blood pressure, possibly due to lack
of vascular involvement in influenza infection. Increased
vascular permeability, on the other hand, is central to the
pathogenesis of dengue infection.
Levels of serum GGT peak during acute illness and fall
(but not normalizing to control levels) at month 3. Increase in
oxidative damage is also supported by correspondingly lower
levels of uric acid which, in vivo, has been suggested to be a
potent antioxidant (1). Significant changes in plasma allan-
toin, a product of attack upon urate by ROS, were observed
during acute infection. Even higher levels were seen at month
3, indicative of ongoing oxidative damage, especially as al-
lantoin levels seem to normalize quickly when oxidative
stress ceases (8). We did not observe an increase in circula-
tory nitrite or nitrate during influenza infection. Instead, ni-
trate appeared to be lower during acute illness. Levels of both
plasma nitrite and nitrate were lower during acute illness,
suggesting decreased nitric oxide production and, conse-
quently, endothelial dysfunction.
We observed higher baseline levels of plasma F2-isoprostanes
and F4-neuroprostanes in patients with postinfectious fatigue
comparedwith those without fatigue. By contrast, patients with
musculoskeletal complaints such as myalgia and arthralgia had
higher baseline hsCRP, but not biomarkers of oxidative dam-
age. Together, these data suggest a modulatory role of ROS in
immune activation, important both in the eradication of viral
infection and immune-induced cellular injury.
Notes
Study population
Subjects attending the Emergency Room at the National
University Hospital, Singapore, with influenza-like symp-
toms were screened. Recruitment criteria included the pres-
ence of fever and at least two of the following symptoms
(cough, sore throat, rhinorrhea, and/or myalgia). Information
on age, gender, clinical parameters, and comorbidities was
collected after written informed consent was obtained. Each
FIG. 5. Comparisons in the (A) adjusted levels of plasma total hydroxyeicosatetraenoic products (HETEs), (B)
serum high-sensitivity C-reactive protein (hsCRP), (C) plasma nitrite, and (D) plasma nitrate between age-matched
controls and patients during acute illness and at month 3. Each graphical column expresses mean – standard deviation.
*p < 0.05 using the unpaired Student’s t-test versus controls, while #p< 0.05 using the paired t-test between acute illness and
at month 3.
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subject was administered a detailed questionnaire to deter-
mine their symptoms and severity (0 = none; 1 =mild;
2 =moderate; 3= severe). The sum of these scores was used
to indicate symptom severity.
Study subjects were invited to return 3 months later.
During this review, they were administered the same ques-
tionnaire on symptom severity. The presence of fatigue was
determined using a fatigue questionnaire (FQ). Briefly, the
FQ is a validated questionnaire, consisting of 11 items that
measure the physical and mental dimensions of fatigue.
Physical fatigue corresponds to the subjective feeling of be-
ing exhausted and lacking energy, whereas mental fatigue
describes the subjective feeling of being mentally exhausted,
incorporating items on concentration, memory, and speech.
The seven items on physical fatigue and the four items on
mental fatigue have four response categories (0 = none;
FIG. 7. Acute levels of serum hsCRP in patients with persistent (A) myalgia and (B) arthralgia at month 3. Each
graphical column expresses mean – standard deviation.
FIG. 6. Acute levels of (A) plasma F2-isoprostanes, (B) plasma F4-neuroprostanes, (C) plasma total HETEs, and (D)
serum hsCRP in patients with or without postinfectious fatigue at month 3. Each graphical column expresses
mean – standard deviation. *p < 0.05 using the unpaired Student’s t-test versus controls.
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1 =mild; 2 =moderate; 3 = severe). Thus, higher scores imply
more fatigue, with a maximum scale score of 33. Fatigue is
considered to be clinically significant when the fatigue score
is > 4 (2). Age- and gender-matched healthy volunteers were
recruited to serve as study controls. The study protocol was
reviewed and approved by the Domain Specific Review
Board, National Healthcare Group, Singapore.
Measurement of biomarkers
Blood and urine samples were collected from patients into
EDTA and plain tubes during each visit. Blood samples were
centrifuged at 2800 rpm for 15min to derive plasma and se-
rum. Indomethacin (3 ll 5mM to 1ml of plasma) and bu-
tylated hydroxytoluene (20ll 2mM to 1ml of plasma) were
added into plasma samples to prevent artifactual oxidation
during storage at - 80C.
F2-isoprostanes, total HETEs, F4-neuroprostanes, COPs,
allantoin, nitrite, and nitrate were measured in plasma by
gas chromatography–mass spectrometry (Agilent Technol-
ogies). To take into account the precursor levels of these
metabolites, arachidonate, docosahexaenoate, cholesterol,
and urate levels were measured. Urinary F2-isoprostanes
were expressed per unit creatinine. Low-density lipoprotein
cholesterol and high-density lipoprotein cholesterol, hsCRP,
creatinine, and glucose concentrations were measured in se-
rum using the Cobas c111 Photometric Analyzer (Roche
Diagnostic GmbH).
Statistical analyses
Statistical analyses were performed using SPSS version
20.0 (SPSS, Inc.). Mean (standard deviation) was used to
describe parametric data, while median (interquartile range)
was used to describe nonparametric data. For normally
distributed data, between-group (influenza vs. controls) and
within-group (acute illness and at month 3) differences
were analyzed using unpaired and paired t-tests, respec-
tively. For nonparametric data, between-group and within-
group differences were analyzed using Mann–Whitney
unpaired and Wilcoxon paired tests, respectively. Pearson
correlation analysis was used to assess the relationships
between various biomarkers. Statistical significance was set
as p < 0.05.
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